logo
Share SHARE
FONT-SIZE Plus   Neg

USPTO Affirms Gevo's Request For Reexamination Of Butamax Patent

Gevo Inc. (GEVO) announced that the U.S. Patent Office and Trademark or USPTO has denied a petition by Butamax Advanced Biofuels, LLC which would have vacated the order granting Gevo's reexamination request of Butamax's U.S. Patent No. 7,851,188. In so doing, the USPTO simultaneously affirmed its original decision that all claims challenged by Gevo in the '188 patent remain rejected as unpatentable.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT